Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00458302
Status:
COMPLETED
Last Update Posted:
2012-12-19
First Post:
2007-04-06
Brief Title:
Treatment Simplification by DarunavirRitonavir 800100 mg Once a Day Versus a Triple Combination Therapy With DarunavirRitonavir
Sponsor:
Janssen-Cilag International NV
Organization:
Janssen-Cilag International NV
Organization Data
Organization:
Janssen-Cilag International NV
Class:
INDUSTRY
Study ID:
CR013159
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen-Cilag International NV
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None